
BioNTech increases 2021 COVID-19 vaccine supply forecast to two billion doses
German company BioNTech, which developed the first coronavirus vaccine approved in the West, said on Monday it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast.
“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated six-dose label,” said the company, referring to an additional dose that could be extracted from each vial of the vaccine.
European regulators last week approved doctors drawing six doses from each vial, boosting dosage capacity by 20 per cent.
The Mainz-based company, which developed the jab with US giant Pfizer, is planning to open a new factory in Marburg, Germany, in February, expected to ramp up production capacity by 750 million doses a y